3-15453846-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_005677.4(COLQ):c.1281C>A(p.Cys427*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_005677.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLQ | NM_005677.4 | c.1281C>A | p.Cys427* | stop_gained | Exon 16 of 17 | ENST00000383788.10 | NP_005668.2 | |
COLQ | NM_080538.2 | c.1251C>A | p.Cys417* | stop_gained | Exon 16 of 17 | NP_536799.1 | ||
COLQ | NM_080539.4 | c.1179C>A | p.Cys393* | stop_gained | Exon 15 of 16 | NP_536800.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLQ | ENST00000383788.10 | c.1281C>A | p.Cys427* | stop_gained | Exon 16 of 17 | 1 | NM_005677.4 | ENSP00000373298.3 | ||
COLQ | ENST00000603808.5 | c.1284C>A | p.Cys428* | stop_gained | Exon 16 of 17 | 1 | ENSP00000474271.1 | |||
EAF1-AS1 | ENST00000629729.2 | n.128C>A | non_coding_transcript_exon_variant | Exon 2 of 6 | 5 | ENSP00000518887.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1458316Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725266
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Pathogenic:1
This sequence change results in a premature translational stop signal in the COLQ gene (p.Cys427*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 29 amino acids of the COLQ protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of congenital myasthenic syndrome (Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant disrupts the p.Thr441 amino acid residue in COLQ. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15248101, 18180250, 22678886). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at